Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis-Reference-Cited by-同舟云学术

Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis

Published:2018-12-07 Issue:7 Volume:108 Page:749-762
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Vargas Kris G.^ORCID,Haller Paul M.,Jäger Bernhard,Tscharre Maximilian,Binder Ronald K.,Mueller Christian,Lindahl Bertil,Huber Kurt

Funder

Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) and by the Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-018-1403-3.pdf

Reference42 articles.

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD; Biomarker Subcommittee, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA; ECG Subcommittee, Chaitman BR, Clemmensen PM, Johanson P, Hod H; Imaging Subcommittee, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ; Classification Subcommittee, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW; Intervention Subcommittee, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J; Trials & Registries Subcommittee, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML; Trials & Registries Subcommittee, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G; Trials & Registries Subcommittee, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D; Trials & Registries Subcommittee, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60(16):1581–1598. https://doi.org/10.1016/j.jacc.2012.08.001

2. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Group ESC Scientific Document Group (2018) Fourth universal definition of myocardial infarction (2018). Eur Heart J. https://doi.org/10.1093/eurheartj/ehy462

3. White HD, Thygesen K, Alpert JS, Jaffe AS (2014) Clinical implications of the third universal definition of myocardial infarction. Heart 100(5):424–432. https://doi.org/10.1136/heartjnl-2012-302976

4. Nagele P (2016) The case for a revised definition of myocardial infarction-resolving the ambiguity of type 2 myocardial infarction. JAMA Cardiol 1(3):247–248. https://doi.org/10.1001/jamacardio.2016.0511

5. Alpert JS, Thygesen KA, White HD, Jaffe AS (2014) Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med 127(2):105–108. https://doi.org/10.1016/j.amjmed.2013.09.031

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury;International Journal of Cardiology;2024-05

2. COVID-19 and myocardial injury: Targeting elevated biomarkers for potential novel therapies;Clinics;2024-01

3. Prognostic Significance of Echocardiographic Characteristics in Patients with Type 2 Myocardial Infarction: comparison with Type 1 Myocardial Infarction;Rational Pharmacotherapy in Cardiology;2023-11-07

4. Characteristics and Outcomes of Type 2 Myocardial Infarction;JAMA Cardiology;2022-04-01

5. Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin;European Cardiology Review;2022-02-17